Please use this identifier to cite or link to this item:
Title: Copper complexes of nicotinic-aromatic carboxylic acids as superoxide dismutase mimetics
Authors: Suksrichavalit T.
Prachayasittikul S.
Piacham T.
Isarankura-Na-Ayudhya C.
Nantasenamat C.
Prachayasittikul V.
Keywords: antiinfective agent
aromatic hydrocarbon
biomimetic material
carboxylic acid
nicotinic acid
superoxide dismutase
chemical structure
drug effect
infrared spectrophotometry
microbiological examination
Anti-Infective Agents
Biomimetic Materials
Carboxylic Acids
Free Radical Scavengers
Hydrocarbons, Aromatic
Microbial Sensitivity Tests
Models, Molecular
Spectrophotometry, Infrared
Superoxide Dismutase
Issue Date: 2008
Abstract: Nicotinic acid (also known as vitamin B3) is a dietary element essential for physiological and antihyperlipidemic functions. This study reports the synthesis of novel mixed ligand complexes of copper with nicotinic and other select carboxylic acids (phthalic, salicylic and anthranilic acids). The tested copper complexes exhibited superoxide dismutase (SOD) mimetic activity and antimicrobial activity against Bacillus subtilis ATCC 6633, with a minimum inhibition concentration of 256 μg/mL. Copper complex of nicotinic-phthalic acids (CuNA/Ph) was the most potent with a SOD mimetic activity of IC 50 34.42 μM. The SOD activities were observed to correlate well with the theoretical parameters as calculated using density functional theory (DFT) at the B3LYP/LANL2DZ level of theory. Interestingly, the SOD activity of the copper complex CuNA/Ph was positively correlated with the electron affinity (EA) value. The two quantum chemical parameters, highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO), were shown to be appropriate for understanding the mechanism of the metal complexes as their calculated energies show good correlation with the SOD activity. Moreover, copper complex with the highest SOD activity were shown to possess the lowest HOMO energy. These findings demonstrate a great potential for the development of value-added metallovitamin-based therapeutics. © 2008 by the authors; licensee Molecular Diversity Preservation International.
ISSN: 14203049
Appears in Collections:SCOPUS 1983-2021

Files in This Item:
There are no files associated with this item.

Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.